A citation-based method for searching scientific literature

Tomonori Ozaki, Tatsuya Kawamoto, Yuki Iimori, Nobuaki Takeshita, Yukiko Yamagishi, Hiroaki Nakamura, Masazumi Kamohara, Kaori Fujita, Masayuki Tanahashi, Noriyuki Tsumaki. Sci Rep 2020
Times Cited: 2







List of co-cited articles
13 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Achondroplasia.
William A Horton, Judith G Hall, Jacqueline T Hecht. Lancet 2007
280
100

Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.
Akihiro Yamashita, Miho Morioka, Hiromi Kishi, Takeshi Kimura, Yasuhito Yahara, Minoru Okada, Kaori Fujita, Hideaki Sawai, Shiro Ikegawa, Noriyuki Tsumaki. Nature 2014
129
100

Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial.
Ravi Savarirayan, Louise Tofts, Melita Irving, William Wilcox, Carlos A Bacino, Julie Hoover-Fong, Rosendo Ullot Font, Paul Harmatz, Frank Rutsch, Michael B Bober,[...]. Lancet 2020
26
100

Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model.
Davide Komla-Ebri, Emilie Dambroise, Ina Kramer, Catherine Benoist-Lasselin, Nabil Kaci, Cindy Le Gall, Ludovic Martin, Patricia Busca, Florent Barbault, Diana Graus-Porta,[...]. J Clin Invest 2016
43
100

Statins do not inhibit the FGFR signaling in chondrocytes.
B Fafilek, M Hampl, N Ricankova, I Vesela, L Balek, M Kunova Bosakova, I Gudernova, M Varecha, M Buchtova, P Krejci. Osteoarthritis Cartilage 2017
8
100

Final adult height in long-term growth hormone-treated achondroplasia patients.
Daisuke Harada, Noriyuki Namba, Yuki Hanioka, Kaoru Ueyama, Natsuko Sakamoto, Yukako Nakano, Masafumi Izui, Yuiko Nagamatsu, Hiroko Kashiwagi, Miho Yamamuro,[...]. Eur J Pediatr 2017
17
100

TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3-Related Skeletal Dysplasias.
Vibeke Miller Breinholt, Caroline E Rasmussen, Per Holse Mygind, Mads Kjelgaard-Hansen, Frank Faltinger, Ana Bernhard, Joachim Zettler, Ulrich Hersel. J Pharmacol Exp Ther 2019
19
100

Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain.
Ling Jin, Yosuke Nonaka, Shin Miyakawa, Masatoshi Fujiwara, Yoshikazu Nakamura. Mol Ther 2016
22
100

Limb lengthening in achondroplasia.
Sanjay K Chilbule, Vivek Dutt, Vrisha Madhuri. Indian J Orthop 2016
13
100

Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway.
A Yasoda, Y Ogawa, M Suda, N Tamura, K Mori, Y Sakuma, H Chusho, K Shiota, K Tanaka, K Nakao. J Biol Chem 1998
157
100

Rationale, design, and methods of a randomized, controlled, open-label clinical trial with open-label extension to investigate the safety of vosoritide in infants, and young children with achondroplasia at risk of requiring cervicomedullary decompression surgery.
Ravi Savarirayan, Melita Irving, Wirginia Maixner, Dominic Thompson, Amaka C Offiah, Daniel Ja Connolly, Ashok Raghavan, James Powell, Marcin Kronhardt, George Jeha,[...]. Sci Prog 2021
4
100

Novel therapeutic approaches for the treatment of achondroplasia.
Laurence Legeai-Mallet, Ravi Savarirayan. Bone 2020
8
100

In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia.
Diogo Gonçalves, Guylène Rignol, Pierre Dellugat, Guido Hartmann, Stephanie Sarrazy Garcia, Jeffrey Stavenhagen, Luca Santarelli, Elvire Gouze, Christian Czech. PLoS One 2020
3
100

Development in children with achondroplasia: a prospective clinical cohort study.
Penelope J Ireland, Samantha Donaghey, James McGill, Andreas Zankl, Robert S Ware, Verity Pacey, Jenny Ault, Ravi Savarirayan, David Sillence, Elizabeth Thompson,[...]. Dev Med Child Neurol 2012
25
50

Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
Takei Kake, Hidetomo Kitamura, Yuichiro Adachi, Tetsuro Yoshioka, Tomoyuki Watanabe, Hiroaki Matsushita, Toshihito Fujii, Eri Kondo, Takanori Tachibe, Yosuke Kawase,[...]. Am J Physiol Endocrinol Metab 2009
59
50

Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias.
Cristina A de Frutos, Sonia Vega, Miguel Manzanares, Juana M Flores, Hector Huertas, M Luisa Martínez-Frías, M Angela Nieto. Dev Cell 2007
65
50

SADDAN syndrome.
K V S Hari Kumar, Altamash Shaikh, Ruchita Sharma, Pitamber Prusty. J Pediatr Endocrinol Metab 2011
2
50

Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors.
Chiara Casadei, Nazli Dizman, Giuseppe Schepisi, Maria Concetta Cursano, Umberto Basso, Daniele Santini, Sumanta K Pal, Ugo De Giorgi. Ther Adv Med Oncol 2019
35
50

The effect of different patterns of growth hormone administration on the IGF axis and somatic and skeletal growth of the dwarf rat.
Melissa Westwood, Arfa R Maqsood, Mattea Solomon, Andrew J Whatmore, Julian R E Davis, Robert C Baxter, Evelien F Gevers, Iain C A F Robinson, Peter E Clayton. Am J Physiol Endocrinol Metab 2010
6
50

Cardiac interventions in patients with achondroplasia: a systematic review.
Amrita Sukhavasi, Thomas J O'Malley, Elizabeth J Maynes, Jae Hwan Choi, Jonathan S Gordon, Kevin Phan, Vakhtang Tchantchaleishvili. J Thorac Dis 2020
3
50

Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes.
Iva Gudernova, Iva Vesela, Lukas Balek, Marcela Buchtova, Hana Dosedelova, Michaela Kunova, Jakub Pivnicka, Iva Jelinkova, Lucie Roubalova, Alois Kozubik,[...]. Hum Mol Genet 2016
39
50

Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.
Daniel J Wendt, Melita Dvorak-Ewell, Sherry Bullens, Florence Lorget, Sean M Bell, Jeff Peng, Sianna Castillo, Mika Aoyagi-Scharber, Charles A O'Neill, Pavel Krejci,[...]. J Pharmacol Exp Ther 2015
57
50

Endochondral ossification: how cartilage is converted into bone in the developing skeleton.
E J Mackie, Y A Ahmed, L Tatarczuch, K-S Chen, M Mirams. Int J Biochem Cell Biol 2008
538
50


Parathyroid hormone/parathyroid hormone-related protein receptor signaling is required for maintenance of the growth plate in postnatal life.
Takao Hirai, Andrei S Chagin, Tatsuya Kobayashi, Susan Mackem, Henry M Kronenberg. Proc Natl Acad Sci U S A 2011
55
50

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines.
Mario E Lacouture, Vincent Sibaud, Milan J Anadkat, Benjamin Kaffenberger, Jonathan Leventhal, Kathleen Guindon, Ghassan Abou-Alfa. Oncologist 2021
6
50

Infigratinib (BGJ398): an investigational agent for the treatment of FGFR-altered intrahepatic cholangiocarcinoma.
Gehan Botrus, Puneet Raman, Thomas Oliver, Tanios Bekaii-Saab. Expert Opin Investig Drugs 2021
8
50

Aptamers as Therapeutics.
Shahid M Nimjee, Rebekah R White, Richard C Becker, Bruce A Sullenger. Annu Rev Pharmacol Toxicol 2017
178
50

Assessing physical symptoms, daily functioning, and well-being in children with achondroplasia.
Kathryn M Pfeiffer, Meryl Brod, Alden Smith, Jill Gianettoni, Dorthe Viuff, Sho Ota, R Will Charlton. Am J Med Genet A 2021
6
50

Neurological Manifestations of Achondroplasia.
John B Bodensteiner. Curr Neurol Neurosci Rep 2019
7
50

Epidemiology of achondroplasia: A population-based study in Europe.
Alessio Coi, Michele Santoro, Ester Garne, Anna Pierini, Marie-Claude Addor, Jean-Luc Alessandri, Jorieke E H Bergman, Fabrizio Bianchi, Ljubica Boban, Paula Braz,[...]. Am J Med Genet A 2019
9
50

Familial acanthosis nigricans due to K650T FGFR3 mutation.
David R Berk, Elaine B Spector, Susan J Bayliss. Arch Dermatol 2007
40
50

Birth prevalence of achondroplasia: A systematic literature review and meta-analysis.
Pamela K Foreman, Femke van Kessel, Rosa van Hoorn, Judith van den Bosch, Renée Shediac, Sarah Landis. Am J Med Genet A 2020
8
50

FGF signaling in the osteoprogenitor lineage non-autonomously regulates postnatal chondrocyte proliferation and skeletal growth.
Kannan Karuppaiah, Kai Yu, Joohyun Lim, Jianquan Chen, Craig Smith, Fanxin Long, David M Ornitz. Development 2016
38
50

Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
F Rousseau, J Bonaventure, L Legeai-Mallet, A Pelet, J M Rozet, P Maroteaux, M Le Merrer, A Munnich. Nature 1994
650
50

Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice.
Stéphanie Garcia, Béatrice Dirat, Thomas Tognacci, Nathalie Rochet, Xavier Mouska, Stéphanie Bonnafous, Stéphanie Patouraux, Albert Tran, Philippe Gual, Yannick Le Marchand-Brustel,[...]. Sci Transl Med 2013
57
50

Statins: mechanism of action and effects.
C Stancu, A Sima. J Cell Mol Med 2001
381
50

Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia.
Celine Saint-Laurent, Stephanie Garcia, Vincent Sarrazy, Karine Dumas, Florence Authier, Sophie Sore, Albert Tran, Philippe Gual, Isabelle Gennero, Jean-Pierre Salles,[...]. PLoS One 2018
11
50

Fetal magnetic resonance imaging of skeletal dysplasias.
Leah A Gilligan, Maria A Calvo-Garcia, K Nicole Weaver, Beth M Kline-Fath. Pediatr Radiol 2020
6
50

Cardiovascular risk factors and body composition in adults with achondroplasia.
Svein O Fredwall, Jennifer Linge, Olof Dahlqvist Leinhard, Lisa Kjønigsen, Heidi Beate Eggesbø, Harald Weedon-Fekjær, Ingeborg Beate Lidal, Grethe Månum, Ravi Savarirayan, Serena Tonstad. Genet Med 2021
3
50

Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia.
Masaki Matsushita, Ryusaku Esaki, Kenichi Mishima, Naoki Ishiguro, Kinji Ohno, Hiroshi Kitoh. Sci Rep 2017
5
50

Achondroplasia: a comprehensive clinical review.
Richard M Pauli. Orphanet J Rare Dis 2019
82
50

New developments in the management of achondroplasia.
Wolfgang Högler, Leanne M Ward. Wien Med Wochenschr 2020
5
50

Efficacy of growth hormone therapy for patients with skeletal dysplasia.
Hidemi Kanazawa, Hiroyuki Tanaka, Masaru Inoue, Yoshitaka Yamanaka, Noriyuki Namba, Yoshiki Seino. J Bone Miner Metab 2003
35
50

Pharmacokinetics and safety after once and twice a day doses of meclizine hydrochloride administered to children with achondroplasia.
Hiroshi Kitoh, Masaki Matsushita, Kenichi Mishima, Tadashi Nagata, Yasunari Kamiya, Kohei Ueda, Yachiyo Kuwatsuka, Hiroshi Morikawa, Yasuhiro Nakai, Naoki Ishiguro. PLoS One 2020
2
50

Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.
Jay Y Cho, Changsheng Guo, Monica Torello, Gregory P Lunstrum, Tomoko Iwata, Chuxia Deng, William A Horton. Proc Natl Acad Sci U S A 2004
91
50

Meckel's and condylar cartilages anomalies in achondroplasia result in defective development and growth of the mandible.
Martin Biosse Duplan, Davide Komla-Ebri, Yann Heuzé, Valentin Estibals, Emilie Gaudas, Nabil Kaci, Catherine Benoist-Lasselin, Michel Zerah, Ina Kramer, Michaela Kneissel,[...]. Hum Mol Genet 2016
14
50

Chondrocyte FGFR3 Regulates Bone Mass by Inhibiting Osteogenesis.
Xuan Wen, Xiaogang Li, Yubin Tang, Junzhou Tang, Siru Zhou, Yangli Xie, Jingyuan Guo, Jing Yang, Xiaolan Du, Nan Su,[...]. J Biol Chem 2016
22
50

Achondroplasia: Development, pathogenesis, and therapy.
David M Ornitz, Laurence Legeai-Mallet. Dev Dyn 2017
83
50

Crouzon with acanthosis nigricans. Further delineation of the syndrome.
L Arnaud-López, R Fragoso, J Mantilla-Capacho, P Barros-Núñez. Clin Genet 2007
41
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.